Inventor
Ruth E. TenBrink
Inventor
Kalamazoo, MI, US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07CAcyclic or carbocyclic compounds12%
A61KPreparations for medical, dental or toiletry purposes10%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C07KPeptides3%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
9,549,929'Pyrrolo[2,3-D]pyrimidine derivatives'20179,545,405'Pyrrolo[2,3-D]pyrimidine derivatives'20179,035,074'Pyrrolo[2,3-D]pyrimidine derivatives'20157,727,997'N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives'20107,589,094'N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds'20097,498,436'Substituted hydroxyethylamines'20097,456,163'Macrocycles useful in the treatment of alzheimer\'s disease'20087,442,691'Macrocycles useful in the treatment of alzheimer\'s disease'20087,312,360'Substituted hydroxyethylamines'20077,214,715'Compounds to treat Alzheimer\'s disease'20077,176,242'N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives'20077,067,507'Macrocycles useful in the treatment of Alzheimer\'s disease'20066,969,709'Macrocycles useful in the treatment of Alzheimer\'s disease'20056,932,961'Oxazinocarbazoles for the treatment of CNS diseases'20056,855,709'Pyridyl sulfone derivatives'20056,821,970'Oxazinocarbazoles for the treatment of CNS diseases'20046,514,968'Aminoalkoxy carbazoles for the treatment of cns diseases'20036,448,397'Oxazinocarbazoles for the treatment of CNS diseases'20026,133,446'Heterocyclic compounds for the treatment of CNS and cardiovascular disorders'20006,013,654'Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases'20005,912,246'Imidazo›1,2-a!pyridines for the treatment of CNS and cardiac diseases'19995,877,317'Heterocyclic compounds for the treatment of CNS and cardiovascular disorders'1999RE035840'Imidazo›1,5-a!quinolines for treatment of anxiety and sleep disorders'19985,668,282'4,5-cyclicimidazo[1,5-A]quinoxalines'19975,594,140'Imidazo[1,5-A]quinolines for treatment of anxiety and sleep disorders'19975,541,324'Imidazo[1,5-A]quinoxalines'19964,894,437'Novel renin inhibiting polypeptide analogs containing S-aryl-D- or L- or DL-cysteinyl, 3-(arylthio)lactic acid or 3-(arylthio)alkyl moieties'19904,880,781'Renin inhibitory peptides containing an N-alkyl-histidine moiety'19894,166,062'1-Alkoxyethanol-isochromans, -isothiochromans, -2-benzoxepins, and -2-benzothiepins'1979Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1979–2008Patents assigned to UPJOHN CO (20)· patent assignee history
1979–2009Based in Kalamazoo, MI, US· patent location history
1996–2000Based in Richland, MI, US· patent location history
2007–2010Patents assigned to ELAN PHARM INC (6)· patent assignee history
2008–2017Based in Labadie, MO, US· patent location history
2009Patents assigned to PHARMACIA & UPJOHN CO LLC (1)· patent assignee history
2015–2017Patents assigned to PFIZER (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UPJOHN CO | 20 | 1979–2008 |
| ELAN PHARM INC | 6 | 2007–2010 |
| PFIZER | 3 | 2015–2017 |
| PHARMACIA & UPJOHN CO LLC | 1 | 2009 |
Locations
| Location | Patents | Span |
|---|---|---|
| Kalamazoo, MI, US | 16 | 1979–2009 |
| Richland, MI, US | 7 | 1996–2000 |
| Labadie, MO, US | 6 | 2008–2017 |